Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Early vs Delayed Intravesical Blad-Care During BCG Therapy [NA]
A recruiting clinical trial evaluating early versus delayed intravesical Blad-Care during BCG therapy for bladder cancer and BCG-induced cys…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Cancer Loyalty Card Study 2 (CLOCS-2)
Clinical Trial Update: Cancer Loyalty Card Study 2 (CLOCS-2) from Imperial College London indicates the study is currently recruiting for mu…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma [Phase 1]
Phase 1 clinical trial evaluating dual-target Nectin-4/HER2 CAR-NK cells for advanced urothelial carcinomas, including bladder cancer, is cu…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer [Phase 1, Phase 2]
A study of Enfortumab Vedotin, alone or with other therapies, for urothelial cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer [Phase 1]
A Phase 1 study of PF-07921585 alone or with other anti-cancer medicines in multiple cancers has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors [NA]
A Rutgers-sponsored clinical trial aims to improve coordination between cancer care teams and primary care for complex cancer survivors. The…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Metabolism Evaluation Through Resting Indirect Calorimetry in Bladder Cancer (METRICS)
A bladder cancer clinical study evaluating energy metabolism using resting indirect calorimetry, currently recruiting at University of Kansa…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Evaluation of VISIOCYT Bladder Cytology in Real Life
A completed clinical trial evaluating VISIOCYT bladder cytology for real-world performance in bladder cancer.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma [Phase 2, Phase 3]
A Phase 2/3 clinical trial update evaluating datopotamab deruxtecan plus platinum chemotherapy versus gemcitabine plus platinum in locally a…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Recovery Support for Bladder Cancer Patients and Caregivers [NA]
Completed clinical trial evaluating recovery support for bladder cancer patients and their caregivers, focusing on patient engagement and em…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Bio Clinical Collection of Urothelial Carcinoma
This clinical trial update describes the Bio Clinical Collection of Urothelial Carcinoma trial, sponsored by University Hospital, Toulouse, …
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies [Phase 1, Phase 2]
Phase 1/2 trial of plinabulin with radiation and immunotherapy in select advanced cancers after progression on PD-1/PD-L1 therapy was termin…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: COMPARISON OF OBTURATOR NERVE BLOCK TECHNIQUES IN TURBT [NA]
A completed clinical trial comparing obturator nerve block techniques used during transurethral resection of bladder tumor in bladder cancer…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Window of Opportunity Phase I Study of UGN-201 in Patients With Bladder Cancer Undergoing Radical Cystectomy Protocol #: 2021-0630 [Phase 1]
A Phase I 'window of opportunity' study of UGN-201 in bladder cancer patients undergoing radical cystectomy is being conducted, with the tri…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer [Phase 3]
Phase 3 trial update assessing intravesical TARA-002 versus investigator's choice intravesical chemotherapy for BCG-naïve high-grade non-mus…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy [NA]
A clinical trial comparing mannitol versus nitroglycerin to prevent acute kidney injury during robotic-assisted radical prostatectomy or cys…
-
CLINICAL_TRIALS withdrawal · 2026-03-17Clinical Trial Update: A Study of NDV-01 as an Intravesical Administration to Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC), Refractory to First-line Therapy [Phase 3]
Relmada Therapeutics has withdrawn its Phase 3 trial of NDV-01 administered intravesically for BCG-unresponsive non-muscle invasive bladder …
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Feasibility Study of Urinary cfDNA Analysis as a Non-invasive Monitoring Tool in Patients With Prostate or Bladder Cancer
Feasibility study evaluating urinary cell-free DNA as a non-invasive monitoring tool in prostate cancer and bladder cancer.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Bladder Bank (a Prospective Banking Study)
This is a status update for a prospective bladder cancer biobanking study (Bladder Bank) sponsored by Mayo Clinic, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer.
A feasibility study sponsored by Origin Sciences is recruiting to investigate rectal mucus in aero-digestive tract cancers, including Non-Sm…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer [Phase 1]
Phase 1 clinical trial evaluating IO102-IO103 in combination with pembrolizumab for high-risk non-muscle invasive bladder cancer that is unr…
-
CLINICAL_TRIALS other · 2026-03-13Clinical Trial Update: Effects of a Neuroscience-based Technique on Cancer Patients Announced of a Palliative Disease Progression and Partners [Phase 2]
A Phase 2 clinical trial update notes termination of a study evaluating a neuroscience-based technique in colorectal cancer, bladder cancer,…
-
CLINICAL_TRIALS other · 2026-03-12Clinical Trial Update: Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery [Phase 2]
A Phase 2 clinical trial evaluating multimodal prehabilitation alone or with neoadjuvant therapy before major cancer surgery is currently re…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Study of NDV-01 (Sustained-release Gemcitabine-docetaxel) in Participants With Non-muscle Invasive Bladder Cancer [Phase 3]
Relmada Therapeutics is evaluating NDV-01, a sustained-release gemcitabine-docetaxel formulation, in Phase 3 for non-muscle invasive bladder…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer [Phase 2]
This document provides a status update on a Phase 2 trial evaluating intravesical gemcitabine and docetaxel for low-grade, intermediate-risk…